3-amino-4-chloro-N-(2-ethoxyphenyl)benzamide
- $188 - $362.52
- Product name: 3-amino-4-chloro-N-(2-ethoxyphenyl)benzamide
- CAS: 791803-08-2
- MF: C15H15ClN2O2
- MW: 290.74
- EINECS:
- MDL Number:MFCD05882590
- Synonyms:3-amino-4-chloro-N-(2-ethoxyphenyl)benzamide;Benzamide, 3-amino-4-chloro-N-(2-ethoxyphenyl)-
4 prices
Selected condition:
Brand
- AK Scientific
- Alichem
- Crysdot
Package
- 250mg
- 1g
- ManufacturerAK Scientific
- Product number5789AJ
- Product description3-Amino-4-chloro-N-(2-ethoxyphenyl)benzamide
- Packaging250mg
- Price$188
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number791803082
- Product description3-Amino-4-chloro-N-(2-ethoxyphenyl)benzamide
- Packaging250mg
- Price$347.44
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number791803082
- Product description3-Amino-4-chloro-N-(2-ethoxyphenyl)benzamide
- Packaging1g
- Price$362.52
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12030646
- Product description3-Amino-4-chloro-N-(2-ethoxyphenyl)benzamide 97%
- Packaging1g
- Price$342
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 5789AJ | 3-Amino-4-chloro-N-(2-ethoxyphenyl)benzamide | 250mg | $188 | 2021-12-16 | Buy |
Alichem | 791803082 | 3-Amino-4-chloro-N-(2-ethoxyphenyl)benzamide | 250mg | $347.44 | 2021-12-16 | Buy |
Alichem | 791803082 | 3-Amino-4-chloro-N-(2-ethoxyphenyl)benzamide | 1g | $362.52 | 2021-12-16 | Buy |
Crysdot | CD12030646 | 3-Amino-4-chloro-N-(2-ethoxyphenyl)benzamide 97% | 1g | $342 | 2021-12-16 | Buy |
Properties
Boiling point :396.9±42.0 °C(Predicted)
Density :1.303±0.06 g/cm3(Predicted)
pka :12.36±0.70(Predicted)
Density :1.303±0.06 g/cm3(Predicted)
pka :12.36±0.70(Predicted)
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|